Quick Takeaways
- JNJ - JOHNSON & JOHNSON has 36 insiders with reported activity on this page.
- Net insider value flow over the last year: -$123,099,382.
- Recent transaction rows are available for direct filing-level review.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 36 Insiders of JOHNSON & JOHNSON
- Symbol
- JNJ on NYSE
- Location
- New Brunswick, NJ
What Changed
- Buy value: $257,688; sell value: $123,357,069.
- Net share flow: -578,605.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$123,099,382.
Buys
$257,688
Shares: 1,250
Insiders: 1
Sells
$123,357,070
Shares: 579,855
Insiders: 8
Net
-$123,099,382
Shares: -578,605
Insiders: -7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 339,882 | $0 | $80,476,339 | -$80,476,339 |
| 3-6 | 1,250 | 21,721 | $257,688 | $4,185,793 | -$3,928,106 |
| 6-9 | 0 | 218,252 | $0 | $38,694,938 | -$38,694,938 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
JOHNSON & JOHNSON executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Alex Gorsky | Director | $132,153,735 | Mixed | 17 Jan 2023 | ||
| Joaquin Duato | CEO and Chairman of the Board, Director | $88,349,558 | -$44,671,548 | -34% | Mixed | 13 Feb 2026 |
| Jennifer L. Taubert | EVP, WWC. Innovative Medicine | $48,204,011 | -$10,040,883 | -17% | Mixed | 13 Feb 2026 |
| Michael H. Ullmann | Exec VP, General Counsel | $31,906,242 | Mixed | 14 Feb 2022 | ||
| Kathryn E. Wengel | EVP, Chief TO and Risk Officer | $28,204,107 | Mixed | 13 Feb 2026 | ||
| Peter Fasolo | Exec VP, Chief HR Officer | $21,756,253 | Mixed | 15 Feb 2024 | ||
| Joseph J. Wolk | Exec VP, CFO | $20,446,898 | -$24,743,398 | -55% | Mixed | 13 Feb 2026 |
| Thibaut Mongon | Exec VP, WW Chair, Cons Health | $15,974,106 | Mixed | 13 Feb 2023 | ||
| Mathai Mammen | EVP, Pharm, R&D | $10,751,687 | Mixed | 14 Feb 2022 | ||
| John C. Reed | EVP, Innovative Medicine, R&D | $10,315,169 | -$20,420,856 | -66% | Mixed | 15 Feb 2026 |
| James D. Swanson | Evp, Cio | $10,018,736 | -$15,109,759 | -60% | Mixed | 13 Feb 2026 |
| William Hait | EVP, Chief EI and Med Officer | $9,578,502 | Mixed | 15 Feb 2024 | ||
| Ashley McEvoy | EVP, WW Chair, MedTech | $9,484,760 | Mixed | 23 Aug 2023 | ||
| Vanessa Broadhurst | EVP, Global Corp Affairs | $8,400,124 | -$1,508,288 | -15% | Mixed | 13 Feb 2026 |
| Timothy Schmid | EVP, WW Chair, MedTech | $6,911,910 | -$5,852,268 | -46% | Mixed | 20 Feb 2026 |
| Elizabeth Forminard | EVP, Chief Legal Officer | $6,235,591 | Mixed | 13 Feb 2026 | ||
| Robert J. Decker | VP Corporate Controller | $6,221,796 | -$1,010,070 | -14% | Mixed | 27 Feb 2026 |
| Kristen Mulholland | EVP, Chief HR Officer | $5,096,972 | Mixed | 13 Feb 2026 | ||
| A. Eugene Washington | Director | $4,542,828 | Mixed | 07 Mar 2023 | ||
| Ronald A. Williams | Director | $4,082,264 | Mixed | 15 Feb 2022 | ||
| Charles O Prince | Director | $3,947,229 | Mixed | 15 Feb 2022 | ||
| Anne M. Mulcahy | Director | $3,481,675 | Mixed | 25 Apr 2024 | ||
| Mark B. McClellan | Director | $2,897,429 | Mixed | 24 Apr 2025 | ||
| Marillyn A. Hewson | Director | $2,860,628 | Mixed | 09 Dec 2025 | ||
| Ian Davis | Director | $2,815,437 | Mixed | 15 Feb 2022 | ||
| D. Scott Davis | Director | $2,589,274 | Mixed | 25 Apr 2024 | ||
| Mary C. Beckerle | Director | $2,212,351 | Mixed | 24 Apr 2025 | ||
| Mark A. Weinberger | Director | $1,627,636 | Mixed | 24 Apr 2025 | ||
| Jennifer A. Doudna | Director | $1,310,518 | Mixed | 24 Apr 2025 | ||
| Hubert Joly | Director | $1,048,226 | Mixed | 24 Apr 2025 | ||
| Eugene A. Woods | Director | $1,022,336 | Mixed | 10 Mar 2026 | ||
| Nadja West | Director | $825,991 | Mixed | 24 Apr 2025 | ||
| Darius Adamczyk | Director | $602,052 | Mixed | 25 Apr 2024 | ||
| Paula A. Johnson | Director | $481,960 | Mixed | 24 Apr 2025 | ||
| John George Morikis | Director | $381,070 | +$257,688 | +209% | Filing P/S | 26 Nov 2025 |
| Daniel E. Pinto | Director | $66,948 | Mixed | 10 Mar 2026 |
Top shareholders of JOHNSON & JOHNSON (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
240,349,660
|
$49,740,362,171 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.7%
|
208,781,159
|
$43,207,260,821 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
5.6%
|
133,869,843
|
$27,704,364,009 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.4%
|
58,558,238
|
$12,118,628,064 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
57,953,747
|
$11,967,946,703 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
46,325,589
|
$9,587,081,210 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
33,459,884
|
$6,924,522,994 | — | 31 Dec 2025 | |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO |
13F
|
Company |
1.3%
|
31,590,952
|
$6,537,747,516 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
29,281,433
|
$6,059,792,561 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
28,333,601
|
$5,863,638,896 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
24,394,280
|
$5,048,396,090 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.96%
|
23,238,388
|
$4,809,184,395 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
19,034,302
|
$3,939,527,191 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.78%
|
18,776,671
|
$3,885,832,090 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.78%
|
18,744,587
|
$3,879,192,279 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.74%
|
17,845,244
|
$3,693,073,281 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
17,275,937
|
$3,575,255,163 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.72%
|
17,255,149
|
$3,570,957,689 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.68%
|
16,388,566
|
$3,391,613,735 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
16,340,072
|
$3,381,577,979 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.59%
|
14,287,561
|
$2,956,810,000 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.56%
|
13,494,166
|
$2,792,617,654 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.56%
|
13,446,440
|
$2,782,740,962 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.53%
|
12,725,881
|
$2,633,620,969 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.52%
|
12,423,886
|
$2,571,124,000 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.47%
|
11,405,681
|
$2,360,405,715 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.45%
|
10,795,058
|
$2,234,036,933 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.44%
|
10,609,171
|
$2,195,567,939 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.43%
|
10,358,905
|
$2,143,761,847 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
9,984,291
|
$2,066,249,024 | — | 31 Dec 2025 | |
| Capital World Investors |
13F
|
Company |
0.4%
|
9,692,884
|
$2,005,942,345 | — | 31 Dec 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.38%
|
9,237,953
|
$1,911,877,489 | — | 31 Dec 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.37%
|
8,866,207
|
$1,834,861,808 | — | 31 Dec 2025 | |
| GQG Partners LLC |
13F
|
Company |
0.32%
|
7,752,266
|
$1,604,336,241 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.32%
|
7,723,981
|
$1,598,481,647 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.32%
|
7,695,402
|
$1,592,563,444 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.31%
|
7,471,031
|
$1,546,129,863 | — | 31 Dec 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.31%
|
7,439,241
|
$1,539,550,925 | — | 31 Dec 2025 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.29%
|
7,089,139
|
$1,467,097,661 | — | 31 Dec 2025 | |
| JOURNEY STRATEGIC WEALTH LLC |
13F
|
Company |
0.29%
|
7,052,942
|
$1,459,606,440 | — | 31 Dec 2025 | |
| Ninety One UK Ltd |
13F
|
Company |
0.28%
|
6,810,748
|
$1,409,484,211 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
6,599,607
|
$1,365,788,669 | — | 31 Dec 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.25%
|
6,019,228
|
$1,245,679,234 | — | 31 Dec 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.25%
|
5,985,190
|
$1,238,635,074 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.25%
|
5,946,335
|
$1,230,594,028 | — | 31 Dec 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.23%
|
5,609,012
|
$1,160,785,018 | — | 31 Dec 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.23%
|
5,460,452
|
$1,128,675,429 | — | 31 Dec 2025 | |
| Mitsubishi UFJ Asset Management Co., Ltd. |
13F
|
Company |
0.22%
|
5,278,800
|
$1,094,504,612 | — | 31 Dec 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.22%
|
5,194,401
|
$1,074,981,261 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.21%
|
5,042,090
|
$1,043,460,510 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for JOHNSON & JOHNSON
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Marillyn A. Hewson | JNJ | Deferred Share Units | Award | 1.44% | 206 | 14,513 | 10 Mar 2026 | Direct | ||
| Daniel E. Pinto | JNJ | Deferred Share Units | Award | 38.8% | 129 | 462 | 10 Mar 2026 | Direct | ||
| Eugene A. Woods | JNJ | Deferred Share Units | Award | 3.05% | 155 | 5,240 | 10 Mar 2026 | Direct | ||
| Robert J. Decker | JNJ | Common Stock | Sale | -14.7% | $1,010,070 | $247.87 | -4,075 | 23,682 | 27 Feb 2026 | Direct |
| Robert J. Decker | JNJ | Common Stock | Options Exercise | 17.2% | 4,075 | 27,757 | 27 Feb 2026 | Direct | ||
| Robert J. Decker | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | -100% | -4,075 | 0 | 27 Feb 2026 | Direct | ||
| Timothy Schmid | JNJ | Common Stock | Sale | -4.94% | $324,763 | $245.66 | -1,322 | 25,447 | 20 Feb 2026 | Direct |
| Timothy Schmid | JNJ | Common Stock | Sale | -45.8% | $5,527,506 | $244.33 | -22,623 | 26,769 | 18 Feb 2026 | Direct |
| Timothy Schmid | JNJ | Common Stock | Options Exercise | 127.3% | 22,623 | 40,394 | 18 Feb 2026 | Direct | ||
| Timothy Schmid | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | -100% | -22,623 | 0 | 18 Feb 2026 | Direct | ||
| James D. Swanson | JNJ | Common Stock | Sale | -44.4% | $4,980,447 | $242.70 | -20,521 | 25,698 | 17 Feb 2026 | Direct |
| James D. Swanson | JNJ | Common Stock | Options Exercise | 79.8% | 20,521 | 46,219 | 17 Feb 2026 | Direct | ||
| James D. Swanson | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | -100% | -20,521 | 0 | 17 Feb 2026 | Direct | ||
| Joseph J. Wolk | JNJ | Common Stock | Sale | -86.5% | $21,767,827 | $242.80 | -89,654 | 14,000 | 17 Feb 2026 | Direct |
| Joseph J. Wolk | JNJ | Common Stock | Options Exercise | 845.2% | 64,693 | 72,347 | 17 Feb 2026 | Direct | ||
| Joseph J. Wolk | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | -100% | -64,693 | 0 | 17 Feb 2026 | Direct | ||
| John C. Reed | JNJ | Common Stock | Sale | -83.5% | $13,105,233 | $243.00 | -53,931 | 10,658 | 17 Feb 2026 | Direct |
| John C. Reed | JNJ | Common Stock | Options Exercise | 51,648 | 42,868 | 17 Feb 2026 | Direct | |||
| John C. Reed | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | -70.4% | -51,648 | 21,721 | 17 Feb 2026 | Direct | ||
| Vanessa Broadhurst | JNJ | Common Stock | Sale | -21.2% | $1,508,288 | $243.39 | -6,197 | 23,003 | 17 Feb 2026 | Direct |
| James D. Swanson | JNJ | Common Stock | Tax liability | -2.03% | -523 | 25,298 | 15 Feb 2026 | Direct | ||
| James D. Swanson | JNJ | Common Stock | Options Exercise | 4.84% | 1,201 | 26,007 | 15 Feb 2026 | Direct | ||
| James D. Swanson | JNJ | Restricted Share Units | Award | 1,397 | 1,397 | 15 Feb 2026 | Direct | |||
| James D. Swanson | JNJ | Employee Stock Options (Right to Buy) | Award | 19,449 | 19,449 | 15 Feb 2026 | Direct | |||
| James D. Swanson | JNJ | Restricted Share Units | Options Exercise | -71% | -1,201 | 491 | 15 Feb 2026 | Direct | ||
| Kathryn E. Wengel | JNJ | Common Stock | Tax liability | -0.55% | -635 | 113,978 | 15 Feb 2026 | Direct | ||
| Kathryn E. Wengel | JNJ | Common Stock | Options Exercise | 1.09% | 1,241 | 114,613 | 15 Feb 2026 | Direct | ||
| Kathryn E. Wengel | JNJ | Restricted Share Units | Award | 1,217 | 1,217 | 15 Feb 2026 | Direct | |||
| Kathryn E. Wengel | JNJ | Employee Stock Options (Right to Buy) | Award | 16,945 | 16,945 | 15 Feb 2026 | Direct | |||
| Kathryn E. Wengel | JNJ | Restricted Share Units | Options Exercise | -67.2% | -1,241 | 606 | 15 Feb 2026 | Direct | ||
| Kristen Mulholland | JNJ | Common Stock | Tax liability | -2.12% | -423 | 19,506 | 15 Feb 2026 | Direct | ||
| Kristen Mulholland | JNJ | Common Stock | Options Exercise | 5.21% | 994 | 20,081 | 15 Feb 2026 | Direct | ||
| Kristen Mulholland | JNJ | Restricted Share Units | Award | 1,459 | 1,459 | 15 Feb 2026 | Direct | |||
| Kristen Mulholland | JNJ | Employee Stock Options (Right to Buy) | Award | 20,322 | 20,322 | 15 Feb 2026 | Direct | |||
| Kristen Mulholland | JNJ | Restricted Share Units | Options Exercise | -70.4% | -994 | 418 | 15 Feb 2026 | Direct | ||
| Joseph J. Wolk | JNJ | Common Stock | Tax liability | -4.23% | -1,675 | 37,900 | 15 Feb 2026 | Direct | ||
| Joseph J. Wolk | JNJ | Common Stock | Options Exercise | 10.7% | 3,849 | 39,778 | 15 Feb 2026 | Direct | ||
| Joseph J. Wolk | JNJ | Restricted Share Units | Award | 3,863 | 3,863 | 15 Feb 2026 | Direct | |||
| Joseph J. Wolk | JNJ | Employee Stock Options (Right to Buy) | Award | 53,793 | 53,793 | 15 Feb 2026 | Direct | |||
| Joseph J. Wolk | JNJ | Restricted Share Units | Options Exercise | -66.1% | -3,849 | 1,971 | 15 Feb 2026 | Direct | ||
| Robert J. Decker | JNJ | Common Stock | Tax liability | -0.8% | -189 | 23,433 | 15 Feb 2026 | Direct | ||
| Robert J. Decker | JNJ | Common Stock | Options Exercise | 2.96% | 683 | 23,777 | 15 Feb 2026 | Direct | ||
| Robert J. Decker | JNJ | Restricted Share Units | Award | 700 | 700 | 15 Feb 2026 | Direct | |||
| Robert J. Decker | JNJ | Employee Stock Options (Right to Buy) | Award | 4,871 | 4,871 | 15 Feb 2026 | Direct | |||
| Robert J. Decker | JNJ | Restricted Share Units | Options Exercise | -66.9% | -683 | 338 | 15 Feb 2026 | Direct | ||
| John C. Reed | JNJ | Common Stock | Tax liability | -7.28% | -913 | 11,622 | 15 Feb 2026 | Direct | ||
| John C. Reed | JNJ | Common Stock | Options Exercise | 31.1% | 3,196 | 13,469 | 15 Feb 2026 | Direct | ||
| John C. Reed | JNJ | Restricted Share Units | Award | 3,546 | 3,546 | 15 Feb 2026 | Direct | |||
| John C. Reed | JNJ | Employee Stock Options (Right to Buy) | Award | 49,382 | 49,382 | 15 Feb 2026 | Direct | |||
| John C. Reed | JNJ | Restricted Share Units | Options Exercise | -70.3% | -3,196 | 1,349 | 15 Feb 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.